Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin 150 mg vs 100 mg for Preeclampsia Prevention in Obese Pregnant Women
NCT06952712Phase 3Not yet recruiting
- Start
- May 2025
- Primary completion
- May 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in preeclampsia. Planned start May 2025; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT06952712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06952712.